OCGN
#2980
Ocugen, Inc. - Common Stock
1.3 2 USD
-0.04%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-3.65%
Variación mensual
+5.60%
Variación en los últimos 6 meses
-20.48%
Cambio anual
+26.92%
Cierres anteriores
1.3 7
Open
1.3 4
Mínimo
1.3 2
Máximo
1.3 5
Volumen
742
Financials
- Market Capitalization 447.63 M
- Employee 116
- Founded 2013
- CEO Shankar Musunuri
- Website www.ocugen.com
- Headquarter Delaware, United States
- FIGI BBG00194VJB1
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-5.87
Relación precio/flujo de caja
91.83
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2964 |  RLMD Relmada Therapeutics, Inc. - Common Stock | 4.34 USD | -3.98% | -6.26% | -17.02% | +422.89% | 462.95 M USD | ||
| 2979 |  PRLD Prelude Therapeutics Incorporated - Common Stock | 5.47 USD | -13.72% | -17.50% | +17.89% | +324.03% | 436.53 M USD | ||
| 2984 |  AGMB AgomAb Therapeutics NV - ADRs representing one | 13.21 USD | -4.55% | -1.34% | +5.34% | -10.14% | 451.35 M USD | ||
| 2989 |  DNA Ginkgo Bioworks Holdings, Inc. Class A Common Stock | 6.97 USD | -4.13% | -4.26% | -9.48% | -21.51% | 448.45 M USD |